Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world’s first academic Institute focused on young athletes’ safety and lifelong health and will combine Oxford’s longstanding tradition in sports and education with the very best of science, medicine, and technology.

Student looking at a brain scan

The new Institute will shift the traditional emphasis of research into sports injury - which is predominantly adult-centric and based upon treatment – by concentrating on younger athletes, 11-18 years old, and will focus on prevention rather than cure.

The institute will develop new technologies to monitor and analyse the individual factors that currently lead to youth sports injuries and offer practical solutions for safer sports practices, focusing on safety for lifelong health, rather than performance.

‘Sport-related injury, particularly concussion, have rapidly risen to the top of under-reported and under-researched issues with lifelong consequences for both individual athletes and society. This partnership, and the new Institute, will combine the best of science, medicine and technology to deliver research that can have a real-world and measurable impact on young people’s lives.’ Prof Louise Richardson, Vice-Chancellor of the University of Oxford 

The Institute will form part of the Institute of Biomedical Engineering (Department of Engineering Science) - which has a 15-year track-record of combining medicine and technology to achieve adoption and healthcare impact - and will draw on leading expertise across the medical sciences, including clinical neurosciences, orthopaedics, and population health, as well as Oxford’s Big Data Institute

Read the full story on the University of Oxford website

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.